L&E Research
Participate
Client login
Bid request
  • Focus areas
    • L&E Health
    • L&E Consumer
    • L&E Insights
    • L&E Legal
  • Facilities
  • Capabilities
    • Qualitative & Quantitative Recruitment
    • Video Streaming
    • Virtual and Remote Facilities
    • Partnerships
    • Client Portal
  • Resources
    • Information Security for Our Clients
    • Member Privacy Policy
  • Meet us
  • Contact
  • Focus areas
    • L&E Health
    • L&E Consumer
    • L&E Insights
    • L&E Legal
  • Facilities
  • Capabilities
    • Qualitative & Quantitative Recruitment
    • Video Streaming
    • Virtual and Remote Facilities
    • Partnerships
    • Client Portal
  • Resources
    • Information Security for Our Clients
    • Member Privacy Policy
  • Meet us
  • Contact

Rallying for a Cause: L&E Health at Relay for Life

DWG Admin on June 12, 2025

On May 3rd, members of our L&E Health team gathered in Cary, North Carolina, to take part in the Relay for Life, a powerful community event that brings people together to honor cancer survivors, remember loved ones lost, and take action to help end cancer as we know it. This wasn’t just another team outing: it was a moment that reaffirmed who we are, both as individuals and as a company. At L&E Research, we believe in the strength of connection, whether it’s helping our clients find the right people for research or standing side-by-side in support of a cause that touches countless lives.

The event offered our team the opportunity to:

  • Strengthen relationships outside of the workplace
  • Engage meaningfully with our local community
  • Walk in solidarity for a cause that affects so many of us

Through shared stories, laughter, and heartfelt conversations, we left the event more united and inspired. We were honored to meet passionate community members, survivors, caregivers, and fellow advocates who reminded us of the power of hope and the importance of action. And the impact? Together with fellow participants, our team helped raise over $84,000 with donations still coming in. This incredible outcome reflects the generosity, spirit, and unwavering commitment of everyone involved.

To those who participated, donated, or offered words of encouragement – thank you. Your support means the world, and it fuels our shared drive to make a lasting difference. As we reflect on this experience, we’re reminded that being “the people for you” isn’t just a tagline: it’s a way of showing up in every aspect of life. We’re proud to stand with our community in the fight against cancer, and we look forward to continuing this journey of impact together.

Injection Naïve: The New Unicorn?

DWG Admin on March 27, 2025

If you are a human factors engineer, medical device UX researcher or a healthcare market research firm, you have surely experienced a growing difficulty fulfilling injection naive quotas for your injection device usability studies. There has been a dramatic shift over the past decade in recruitment incidence within the injection naive vs injection experienced patient and caregiver segments.

Historically, when designing research outside of diabetes, injection experience was the low incidence cohort. However, over the past decade the pendulum has swung significantly in the other direction making inclusion of true lifetime injection naive patients and caregivers the needles in a haystack. In order to successfully execute injection device usability studies, it is important to understand the current climate as related to injection experience within the US population.

Why The Shift?

There are numerous factors leading to the injection experience incidence shift over the past ten years.

  • Diabetes continues to increase in diagnosis rate annually and is estimated to now affect 12% of the US population rising to 29% in the elderly. While there is an abundance of treatment modalities available, insulin is the #1 prescribed injectable in the US. 23% of diabetic patients self administer insulin.
  • The rise in autoimmune conditions accompanied by the emergence of self-administered biologics. 10% of the US population is affected by an autoimmune condition. Of those diagnosed, 6% are prescribed an injectable biologic.
  • Approximately 10 million patients in the US are diagnosed with osteoporosis. Forteo and Prolia, both injectable treatments and prophylactic approaches to treating osteoporosis are delivered via at-home injection.
  • Hormone replacement therapy diagnostics, education, accessibility and affordability has led to 20 million Americans being placed on an HRT protocol with 1.2 million inclusive of an injectable therapeutic.
  • Allergies and anaphylaxis, especially in children, have risen significantly over the past decade. The CDC now estimates 1 in 4 children have a diagnosed allergy. With that, there is an elevated population of children, and subsequently adults, trained to administer an EpiPen.
  • The growing popularity and now widespread access of injectable GLP-1 agonists will likely be the anchor forever sinking injection naive recruitment feasibility. Millions of Americans have now at least tried an injectable GLP-1 for diabetic management and/or weight loss. These statistics are expected to continue to climb due to the abundance of recently confirmed positive clinical outcomes and widening of regulatory approvals.

Tightened Definition of “Injection Naive”

Despite the growing adoption and prescribing of patient delivered injectable therapies, in recent years we have seen research designers, largely influenced by FDA guidelines, further narrow the definition of the “injection naive” individual. Most impactful is “injection naive” defined as lifetime injection experience with any device for any duration of time.

This is routinely confirmed to include the injection of self, the injection of others, the injection of a pet, being trained to perform an injection including simulation into an injection pad. By default, anyone who participates in an injection device usability study would then be considered “injection experienced”.

Challenges in Recruitment

Given the aforementioned rise in injectable therapies coupled with the tightening of naive definitions, recruitment of injection naive participants is becoming increasingly difficult, if not impossible in the setting of certain conditions.

The US general population is an injection experienced population. While this is great news for the injection experienced quota buckets, seeking patients and caregivers who are truly injection naive is rarely a feasible avenue in the US, especially in the setting of a chronic condition.

The Recommendations 

The most important factor is education and intervention at the design level should a device usability project include a naive segment. As, once the device research methodology is approved, it is incredibly difficult to walk it back and request flexibility and exceptions.

Below are recommendations for ensuring your research is well represented by an injection naive cohort while presenting a segment that is recruitable to your recruiting firm. Including even one of these options in the design of your naive quota qualifiers significantly increases the incidence of recruitment.

  • Be Specific. Tailor your device experience to the device being tested. Autoinjectors, pre-filled syringes, injection pens, infusion and patch pumps, vial/ syringe and wearable injectors all require different techniques of administration. Experience with one does not equate to experience for all.
  • Consider the Time Lapse. A good rule of thumb is 10 years. It is reasonable to assume, especially with the forever changing injection device design, that if an individual has not administered an injection within the past 10 years, they can be considered naive.
  • Be Open to Surrogates. If true, lifetime injection naivety must be a requirement, it will be imperative to open the pool. Especially in the context of a chronic condition, whether patient or caregiver, the recruit criteria will need to allow for the inclusion of proxy participants from the general population to represent the naive cohort.
  • The Screener. It is important that the developed screener clearly distinguishes between injection-naive and injection-experienced individuals. One must take care to ensure the final screener is fully inclusive of all devices, injection methods and time periods as is required to qualify for the research.

We are privileged to conduct medical device usability research in the US. To maintain our progress and prevent recruitment challenges, it is essential for everyone involved in device UX to stay informed about the evolving trends in the adoption and prescription of at-home administered injectables nationwide.

This awareness should be integrated into the development of participant inclusion criteria. By doing so, we can ensure a seamless recruitment process for all parties involved: the client, the recruiting firm, and the participants.

Originally published on GreenBook.org on August 13, 2024.

Human-Centered Research: What We Learned at Intellus 2025

DWG Admin on March 27, 2025

One of the most appreciated aspects of Intellus this year was its intimate atmosphere. Unlike massive industry events, the conference fostered deeper conversations and direct collaboration between agencies, consultants, panel providers, and clients. Seeing familiar names and faces always feels like a reunion, but what stood out most was how closely sessions aligned with the realities of our daily work, tackling tangible issues with actionable insights and practical strategies that healthcare research teams can implement immediately.

At L&E Research, our healthcare team came away energized by key themes: deeper partnerships, thoughtful integration of emerging technologies, and an unwavering focus on the people at the heart of every study: patients, caregivers, and healthcare professionals (HCPs).

Here are our key takeaways shaping how we continue to support our clients and the communities we serve.

From Service Provider to Strategic Partner

The days of simply being a behind-the-scenes research provider are over. Organizations are increasingly looking for true thought partners: teams that provide holistic insights, agile solutions, and a comprehensive understanding of their audience.

At L&E Health, we’re committed to being more than a recruitment partner. We proactively offer perspectives that might otherwise go unnoticed, particularly from harder-to-reach populations like patients and HCPs. Cross-functional collaboration allows us to maintain agility and elevate our role as strategic advisors. It’s about shaping smarter, more human-centered insights.

Technology and the Human Experience

AI was unsurprisingly a central focus at Intellus. The message was clear: organizations must experiment with AI now or risk falling behind. However, adopting AI effectively requires intentional support from leadership to ensure teams have time to explore and build essential skills.

Integrating AI in healthcare research presents challenges alongside opportunities. Can AI-driven chatbots genuinely build rapport? How well can they interpret subtle, nonverbal cues essential in healthcare conversations? While AI offers significant potential – like global consistency, multilingual support, cost efficiency, and geographic reach – it still lacks the critical empathy of human moderation.

A particularly urgent issue raised was adverse event (AE) reporting requirements, which demand a response within 24 hours. If AI is moderating, who’s monitoring in real time? Can we risk missing a serious patient-reported outcome because no human is present to interpret or escalate it?

Another critical tech consideration is accessibility. Mobile-first research methods are essential for reaching participants where they are, particularly busy HCPs and lower-income patient populations whose primary internet connection is their smartphone. However, incompatible technology can unintentionally exclude these critical voices. Addressing this isn’t just a technical issue; it’s fundamental to inclusivity and quality of insights.

The future of AI in healthcare research is promising but requires thoughtful, responsible implementation and human oversight to ensure quality and safety.

Transforming Insights & Analytics

McKinsey Consulting presented a powerful roadmap for healthcare insights teams seeking to increase their strategic impact:

  1. Shift from Passive Reporting to Active Guidance: Insights should proactively inform decisions, driving immediate, practical actions rather than simply generating passive reports.
  1. Ensure Insights & Analytics Has a Voice in Strategic Decisions: Position insights and analytics teams as trusted advisors by consistently involving them early in strategic conversations, enabling insights to shape critical business decisions from inception.
  1. Align Insights Closely with Business Goals: Integrate insights teams directly with specific business units to ensure data-driven insights are not only relevant but quickly actionable, bridging the gap between analytics and strategy execution.
  1. Invest in Effective Storytelling and Communication: Transform insights through powerful storytelling and compelling visualization, making complex data clear, memorable, and actionable for stakeholders.
  1. Enable Agile Decision-Making Through Rapid Testing: Promote a flexible approach to decision-making that quickly tests and refines insights, allowing businesses to respond swiftly to market shifts and new opportunities.
  1. Measure Insights’ Impact by Business Outcomes: Demonstrate the value of insights by directly connecting analytics initiatives with measurable outcomes such as revenue growth, customer engagement, and operational efficiencies.
  1. Regularly Connect Leaders to Consumer Perspectives: Foster deeper, firsthand understanding by routinely exposing business leaders directly to consumer and market insights, enhancing empathy and ensuring decisions are grounded in genuine customer needs.
  1. Consistently Deliver Trusted, Actionable Insights: Build and maintain organizational trust by regularly providing accurate, relevant, and strategically valuable insights that become essential to decision-making and long-term planning.

These strategies resonate with our mission at L&E: empowering healthcare organizations to act quickly, connect meaningfully, and lead with insights driven by authentic patient and provider experiences.

Looking Ahead

Healthcare is deeply personal. The insights we gather must reflect that truth – not just through data, but through the stories, needs, and voices of the people behind the numbers.

As we continue to evolve alongside our clients, our focus remains clear: helping brands navigate complexity with confidence, bring diverse voices into the fold, and leverage the best of both technology and human connection to improve outcomes.

We’re proud to be your partner on that journey.

Let’s keep the conversation going. If your healthcare insights team is rethinking its approach, we’d love to talk about how L&E Health can support your vision. Because when it comes to understanding people, we’re the people for you.

L&E Health Takes Strides in the Fight Against Type 1 Diabetes

DWG Admin on November 25, 2024

In the heart of Denver’s City Park, team L&E Health joined forces with the community for the Breakthrough Diabetes Walk, a vital initiative aimed at raising awareness and funding for type 1 diabetes research. This annual event is more than just a walk; it’s a powerful statement about our collective commitment to transforming lives and finding breakthroughs in diabetes care. At L&E Research, our mission extends beyond the boardroom and into the heart of the communities we serve, reflecting our core value of giving back.

As part of this year’s event, our team was thrilled to engage directly with participants—patients and caregivers alike. We understand the importance of listening to those affected by type 1 diabetes and providing them with opportunities to voice their experiences. Through initiatives like the Breakthrough Walk, we not only raise awareness but also expand our panel of dedicated participants. This expansion is crucial; it allows us to deliver richer insights and better quality data to our clients, ensuring that the voices of patients and caregivers are heard loud and clear in the medical research community.

Team L&E’s involvement goes beyond mere participation. Each step taken and each story shared at the walk underscores our commitment to improving patient outcomes and enhancing the quality of life for those living with type 1 diabetes. The event has been a resounding success, raising over $430,000 thus far, which will directly support diabetes research and initiatives aimed at making significant advancements in treatment and care.

For L&E Research, the benefits of participating in the Breakthrough Diabetes Walk are manifold. Not only do we expand our database with high-quality, verified patient recruits, but we also reinforce our position as a leader in healthcare research dedicated to making a real difference. Our team members, energized by the opportunity to give back and contribute their time to a great cause, return invigorated, and ready to apply new insights and experiences to their work.

The Breakthrough Walk is a testament to what we can achieve together for the diabetes community. It reflects our unwavering support for groundbreaking research and our dedication to the individuals and families affected by type 1 diabetes. At L&E Research, we remain committed to our foundational value of community contribution, striving each day to not only meet but exceed the expectations of the communities we serve and the clients we support.

As we look to future events and the continuous expansion of our research capabilities, we are grateful for the ongoing support of our participants, clients, and team members who make initiatives like the Breakthrough Walk possible. Together, we are not just walking; we are paving the path toward a brighter, healthier future for all.

User-View Case Study

DWG Admin on March 30, 2023

Delivering on promises for User-View

The story

Human factors and design experts User-View have been a long-term partner of L&E. Human factors look at how people interact with the world around them, drawing on psychology, computer science, biomechanics, information design, engineering, and many other fields. 80% of User-View’s work is developing medical device and health IT. They work with clients to gather user, business, and technology requirements before spending resources developing and delivering a product to market. “Most of the work that we do is along the whole spectrum of user experience and human factors,” says Dr Janey Barnes, Human Factors Specialist and Principal at User-View. “For example, I help clients identify unmet needs, understand who their users are and where different applications and products are used.”  To allow products to go on to full approval and launch, projects often require a niche, “hard-to-find” and “hard-to-reach” group of respondents. As a result, User-View has been relying on L&E to recruit the perfect audience to test their clients’ devices, especially during the difficult times of Covid.

Finding the perfect respondent

The key factor for User-View when hiring a recruitment partner is “can they find people who fit the criteria?”. There are different traits that User-View looks for in a respondent. Working alongside the medical device industry is often about finding a specific niche of people, for example, specialized healthcare providers or patients and caregivers of patients with rare diseases. “Especially during COVID, being able to find US healthcare providers willing to participate in studies was a challenge. Although healthcare providers were overloaded and burdened, medical device companies still needed to continue their research and development activities. Even in such challenging circumstances, L&E was still able to provide the participants that we needed to help our clients continue their work.”   With qualitative research, it’s no surprise that you get the best results if you recruit people who actually want to be involved in the research – this is something L&E really helped with. “You might not want somebody who’s combative or somebody who doesn’t want to talk to you. You want people who want to be in the session, and we’re confident that L&E’s respondents will bring value to the project,” Dr Barnes adds.   Finally, there are often geographical requirements. “We know that L&E are specialized in certain regions. However, we also tend to ask them for support if they have trusted partners in other regions that we can work with. We trust them, as they’d point us towards someone who is valuable for our work.”

The benefits of being predictable

After an ongoing partnership of over a decade, User-View knows the benefits of working with L&E well. “We know that L&E will be able to deliver the number of participants that they say that they’re going to deliver. There’s nothing better than that. That’s the best praise that you can give to a recruiting agency as they get you the people that they promised – and they get them on time and within budget.” As Dr Barnes says, when working across several projects in a complex industry, being able to rely on your partner is critical; “it comes to that: reliable. Everything with L&E is predictable. The process is predictable. The cost is predictable. And that helps us with all our processes.” This long-lasting trust and L&E’s ability to be predictable allow User-View to be confident with clients when planning their proposal process, giving precise timelines, and managing their expectations. “We are confident when making a commitment to a client because we already know how many days it’s going to take L&E to provide us with what we need. It makes it easy for us to manage client expectations in terms of scheduling and interactions.” Finding the right partner often brings unexpected benefits. User-View and L&E’s collaboration doesn’t only bring tangible benefits to User-View’s clients, but also to its internal team. “Because L&E is so reliable, I can be very confident for my team to gain knowledge and experience on how to deal with other partners”, Dr Barnes says. “The people on our team who are growing can become project leads. If L&E wasn’t predictable, or if we didn’t know the team, I would always have to be the person getting the quotes. But because of our relationship and thanks to their great services, I can let more junior people work with L&E as a learning experience.” There are a lot of benefits in finding the right recruitment partner, and trust is always the best starting point for a fruitful collaboration. Since User-View and L&E’s partnership started over ten years ago, they’ve been delivering high-quality work in synergy, overcoming even the toughest challenges.

A Prescription for Better Research in 2023: How to Make In-Person Healthcare Research Safe and Effective

DWG Admin on February 7, 2023

A Prescription for Better Research in 2023: How to Make In-Person Healthcare Research Safe and Effective

When the pandemic began in March of 2020, our industry had to (quickly!) figure out how to continue conducting research when stay-at-home orders were implemented.  Researchers had to adapt their methodologies to be more inclusive of remote options.  In our latest webinar, we discussed these necessary modifications to processes and methodologies with researchers in the healthcare space.   L&E Research, along with many companies, had the good fortune of being remotely based for years prior to 2020, so existing processes and metrics were already in place, but we promptly realized that the fortunate were in the minority.  Many companies operated from an office or a central location, and had to adapt their internal or operational processes for remote work.  Not only was there an adaptation to their internal processes, but researchers who conducted in-person research had to additionally adapt the research process.  On the other hand, some researchers were already conducting remote research, so their modifications were minimal.  Those who were working remotely and conducting research remotely had a much easier transition than those who had to change both internal and research processes.   During our webinar we had the opportunity to talk with two researchers who had very different perspectives: one was conducting almost all research remotely already so the changes made were more about strengthening internal processes to increase efficiency, rather than how to continue the work; the other researcher was conducting almost all research in-person and had to make significant leaps to adapt their processes.   The pandemic temporarily halted in-person research, but that halt was the catalyst behind a great deal of innovation in qualitative research.  New processes were developed based on the research needed.

  • When travel bans were implemented for many researchers, but in-person research still needed to be conducted, we worked with our clients to develop and perfect a process that we call Remote Moderation.  Facility staff are trained to be the client’s “boots on the ground” when the researcher cannot be in the same physical space as the participant.  In addition to the usual services you would expect from a facility partner, we ensure paperwork is completed, we reset the room, often including the device being tested, and can instruct or direct the participant when necessary.  The moderator conducts the session remotely via a video conferencing platform, without the need for travel.
  • Home Use Testing (HUT or IHUT) was frequently used to replace in-person usability testing when possible.  Traditionally home use testing is conducted by participants coming into a facility to pick up a product, then test it from their own home for a predetermined amount of time.  During the pandemic, we shipped test devices when that was an option for our clients, which eliminated the need for face-to-face contact. Of course, some products or devices are ineligible for HUT due to intellectual property, size limitations, or price limitations, and those still need to be conducted in-person.
  • After the initial stay-at-home orders were lifted in early summer of 2020, in-person research started to slowly return.  Many clients opted to conduct one-on-one interviews rather than focus groups to limit the risk of possible viral transmission, which reduced the amount of people in the facility at any given time, making it safer for both clients and facility staff.  In addition to reducing the head count in our facility, we implemented multiple improvements to minimize contact, such as electronic sign-in and check-out processes, including incentive distribution via e-gift card, limiting people in shared spaces (i.e. asking them to wait in their car rather than a lobby), mask mandates, touch-free doors, electrostatic sprayers, plexiglass dividers, mandatory surface sanitization between sessions, and more.  In retrospect, we may have gone overboard, but the modifications decreased the risk of transmission, and everyone involved felt like their safety was the number one priority.

There were some misconceptions about healthcare provider recruitment during the pandemic. Many clients delayed their research due to an incorrect assumption that physicians would not be available for research.  This was not indicative of our recruiting experience.  Acute care physicians and practitioners were definitely strained during the pandemic, but non-emergency service providers experienced a slowdown.  Because of stay-at-home orders, many elective procedures were canceled or postponed, so some practitioners experienced a decrease in work over the course of the pandemic.  We saw a higher response rate within our healthcare panel because practitioners suddenly had a lot of free time on their hands and wanted to participate in market research, especially and specifically, remote-based research.   There was an increase of fraudulent behavior, so recruiters had to be very diligent about vetting recruits, especially in the healthcare space, since incentives are higher, therefore more alluring.  Healthcare professionals were validated via online resources to confirm that they were in the profession they stated, and patients had to provide proof of prescription, diagnosis, and/or therapies used before being scheduled for sessions.   Now that we are on the other side of the pandemic…or at least moving toward it, what do we anticipate for the future?  At the core, we’ve learned that we have to be flexible and we have to adapt.  Review internal processes to see if there’s room to streamline or reduce costs.  Research should be fit-for-purpose, so if it can be effectively conducted remotely, why would you want to spend more?  When it comes to device usability or sensory testing, in-person research isn’t going away.  Strive to find a balance and use both remote and in-person methodologies, as there will always be value in utilizing a variety of strategies.   We hope you found this summary to be helpful!  If you didn’t register for this webinar you can watch this webinar in its entirety by clicking here.   Be on the lookout for our next webinar, which will be in Spring of 2023.  If you can’t wait until then, you can always view our on-demand webinars.  Don’t forget to join our mailing list so you can keep up with what is happening at L&E!

Creative Medical Research Case Study

DWG Admin on February 1, 2023

Working as partners with CMR

The story

Creative Medical Research (CMR) is a market research company specializing in global medical device research. They help clients discover unmet needs in the marketplace and evaluate and test ideas for device feasibility and usability. We sat down with them to talk about their relationship with L&E and how it works. L&E started working with CMR in 2016 and has collaborated with them on over 30 recruitment projects and facility hires. As CMR says, what started this long-lasting relationship, and made L&E stand out from other competitors from the get-go, was the team. Their knowledge and experience, their tailored proposals, and the attention to feasibility, really showed L&E’s willingness to meet CMR specific needs and not just send cookie-cutter templates.

Working as partners

A competitive, thought-through proposal is just the first step towards a successful collaboration. This must be followed by a strong and reliable delivery.  What CMR likes about L&E is that “they are willing to go the extra mile. While some other competitors have processes that are set in stone, L&E is flexible and responsive, capable of adapting to the client’s evolving needs and priorities. The L&E team is always willing to have an open conversation about how to best support CMR to deliver consistent work”. CMR considers L&E very much a partner rather than a supplier. The partnership between the two companies evolved throughout the years, and it’s built on mutual trust. What CMR values is the “small company feel” and outstanding customer service, which is challenging to maintain as your business grows. CMR knows that L&E will do everything they can to deliver outstanding work. And L&E knows that CMR will support them and will be reasonable and realistic in their requirements. What CMR truly values about this partnership is L&E’s transparency, responsiveness, and communication; “Those are the things we look for in a recruitment supplier, but they’re rare to find.”

L&E can save the day

CMR specializes in medical device research, so they often need to recruit rare patient groups, and hard-to-reach participants. They find that a lot of recruiters are hard to trust when it comes to finding these types of respondents. L&E, on the other hand, is always realistic and provides honest feedback. CMR turns to L&E because they are willing to give it a go: they know that the job must be done. The FDA requires that specific groups of people are spoken to and surveyed, and there’s no way around it. Covid-19 presented new challenges to CMR: as people became more anxious about their health, taking part in research wasn’t a priority. For a lot of patients this could put their health at further risk. A good example happened recently. CMR were conducting a study and they were working with multiple recruiters across multiple cities. All of them were failing to find the specific target that CMR needed. So, they decided to asked L&E to jump in at very short notice, hoping that they would be able to find the right respondents. They completely rescued the study: “we went to them at short notice with a rescue mission, they were willing to help, and they succeeded.” Another advantage of L&E is that they operate in multiple cities, CMR appreciates the ease of working over several locations but with just one project manager.   Honesty is at the base of trust, and without trust partnerships can’t stand the test of time. L&E is realistic, but willing to do their best, and CMR knows that their best is genuinely going to be their best, and not an empty promise.

​A Prescription for Better Research in 2023: How to Make In-Person Healthcare Research Safe and Effective

DWG Admin on January 31, 2023

Still concerned about conducting in-person healthcare research? When it comes to in-person healthcare research, many are still unsure if face-to-face research can be safely conducted. Not only have safety precautions been implemented, they have been tested and proven effective.  In this webinar we’ll discuss what we’ve learned, new processes and technologies to ensure safety and efficacy, and where we’re headed. Representatives from L&E Research, Emergo by UL, and the American Institutes for Research will discuss challenges the healthcare research industry faced when struck with a global pandemic. Our panel of experts includes: Stephanie Larsen, board-certified human factors professional, providing services to the medical device, pharmaceutical, and therapeutic device industries; Amy Lin, Research Associate serving as the Cognitive Testing Lead to translate clinical effectiveness research into summarized abstracts to improve final written products; and L&E Research’s April Leonard, who brings over 12 years of clinical experience as a Registered Nurse, and nearly 10 years in Qualitative Healthcare recruitment; discussion to be led by L&E Research’s Senior Client Solutions Manager, Kelli Hammock. During this webinar, we will discuss:

  • What healthcare researchers did to pivot their process and adapt to the changing research landscape
  • What companies do to ensure in-person healthcare research is conducted safely when remote methodologies are incompatible with the research objective
  • Technologies and platforms that prove most beneficial to remote healthcare research when usability testing is necessary
  • Remote methodologies most useful in accomplishing research goals
L&E Research

Focus areas

  • L&E Health
  • L&E Consumer
  • L&E Insights
  • L&E Legal
  • CondUX.io

Capabilities

  • Qualitative & Quantitative Recruitment
  • Video Streaming
  • Virtual and Remote Facilities
  • Partnerships
  • Client Portal

Facilities

  • Charlotte
  • Chicago
  • Cincinnati
  • Columbus
  • Denver
  • New York City
  • Orlando
  • Raleigh
  • Tampa

Keep in touch

Subscribe to our newsletter

Linkedin-in X-twitter Youtube
  • © L&E Research
  • PRIVACY